Contacts, documents and full notice history are available with a subscription.
Solicitation NONE Expired 2 notices 1 document

ThinkTrends Software Support FDA-RFQ-75F40125Q00156

Solicitation FDA-RFQ-75F40125Q00156 Copied Notice ID a6685f9737db4bb694652369e84fa7c2 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FDA CENTER FOR DRUG EVALUATION AND RESEARCH
SAM.gov
Posted
Jul 22, 2025
Deadline
Jul 28, 2025
Set-aside
NONE
NAICS
541519
PSC
7A21

Summary

AI-generated · Aug 24, 2025

Provide AI-based OCR within the BEST platform to deliver a PDF data-extraction tool capable of pulling data tables from bioanalytical PDFs with accuracy above 90%, enabling reviewers to filter datasets, perform calculations, and conduct analyses essential to their processes. The solution should be reusable across other Remote Regulatory Assessment (RRA) initiatives, where RRA enables FDA investigators to conduct sponsor site inspections remotely, including voluntary interactive evaluations such as remote livestreaming of operations, teleconferences, and screen sharing, along with requests to review records under existing authority. The FDA has used these tools during the pandemic to support oversight and risk mitigation, with the BEST platform cited as an example.

There is no government payment for bid costs, and the government is not obligated to issue an award based on this solicitation; refer to the attached document for complete details. The two posted records describe the same requirement, with no differences or new information between notices.

As part of the BEST platform, the contractor shall provide an AI-based OCR (Optical Character Recognition) function that provides a PDF extraction solution. The solution shall be able to extract data tables from bioanalytical reports in a PDF format at greater than 90% accuracy level to allow for reviewers to access data in a format which is amenable to filtering specific data sets, performing calculations, and other analyses that are critical to their processes. The government should be able to leverage this solution for other projects that are part of the Remote Regulatory Assessment (RRA) initiatives. RRA allows FDA investigators to perform FDA-regulated sponsor site inspections remotely. It includes voluntary interactive evaluations (such as remote livestreaming video of operations, teleconferences and screen sharing) in addition to requests to review records and other information under existing statutory or regulatory authority. Throughout the pandemic, the FDA has used these tools, domestically and abroad, to help the agency conduct oversight, mitigate risk, and meet critical public health needs. The BEST platform described above is an example of RRA. The government will not pay any costs incurred in crafting bids, nor is the government obligated to issue and award based on this solicitation. See Attached document for complete details.

From Solicitation posted on Jul 22, 2025

As part of the BEST platform, the contractor shall provide an AI-based OCR (Optical Character Recognition) function that provides a PDF extraction solution. The solution shall be able to extract data tables from bioanalytical reports in a PDF format at greater than 90% accuracy level to allow for reviewers to access data in a format which is amenable to filtering specific data sets, performing calculations, and other analyses that are critical to their processes. The government should be able to leverage this solution for other projects that are part of the Remote Regulatory Assessment (RRA) initiatives. RRA allows FDA investigators to perform FDA-regulated sponsor site inspections remotely. It includes voluntary interactive evaluations (such as remote livestreaming video of operations, teleconferences and screen sharing) in addition to requests to review records and other information under existing statutory or regulatory authority. Throughout the pandemic, the FDA has used these tools, domestically and abroad, to help the agency conduct oversight, mitigate risk, and meet critical public health needs. The BEST platform described above is an example of RRA. The government will not pay any costs incurred in crafting bids, nor is the government obligated to issue and award based on this solicitation. See Attached document for complete details.

From Solicitation posted on Jul 28, 2025

Notice history

2
  1. Solicitation Posted Jul 22, 2025
  2. Solicitation LATEST Posted Jul 28, 2025
    • Response Deadline: Jul 28, 2025Jul 31, 2025

Details

Solicitation number FDA-RFQ-75F40125Q00156
Notice ID a6685f9737db4bb694652369e84fa7c2
Notice type Solicitation
Product / Service (PSC) 7A21
NAICS 541519
Set-aside No Set aside used
Place of performance Silver Spring, Maryland
Archive date Aug 12, 2025

Award Information

Not yet awarded

Documents

1
View on SAM.gov

Contacts

primary
Robert Waite

Email

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FOOD AND DRUG ADMINISTRATION
FDA CENTER FOR DRUG EVALUATION AND RESEARCH

Place of Performance

Silver Spring, Maryland 20993
USA

Dates

Posted Jul 22, 2025 1 year ago
Last Updated Aug 06, 2026 1 day ago
Due Jul 28, 2025 1 year ago